JP2022532134A5 - - Google Patents
Info
- Publication number
- JP2022532134A5 JP2022532134A5 JP2021566259A JP2021566259A JP2022532134A5 JP 2022532134 A5 JP2022532134 A5 JP 2022532134A5 JP 2021566259 A JP2021566259 A JP 2021566259A JP 2021566259 A JP2021566259 A JP 2021566259A JP 2022532134 A5 JP2022532134 A5 JP 2022532134A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- referred
- peptide ligand
- cysteine residues
- amino acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962845473P | 2019-05-09 | 2019-05-09 | |
| US62/845,473 | 2019-05-09 | ||
| PCT/GB2020/051144 WO2020225577A1 (en) | 2019-05-09 | 2020-05-11 | Bicyclic peptide ligands specific for ox40 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022532134A JP2022532134A (ja) | 2022-07-13 |
| JP2022532134A5 true JP2022532134A5 (cg-RX-API-DMAC7.html) | 2023-05-17 |
Family
ID=70847426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021566259A Pending JP2022532134A (ja) | 2019-05-09 | 2020-05-11 | Ox40に特異的な二環式ペプチドリガンド |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11613560B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3965827A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022532134A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220007098A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113811541A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020269506A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021022315A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3137095A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL287881A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021013669A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202111606TA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020225577A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ731185A (en) | 2014-10-29 | 2024-03-22 | Bicyclerd Ltd | Bicyclic peptide ligands specific for mt1-mmp |
| WO2019002842A1 (en) | 2017-06-26 | 2019-01-03 | Bicyclerd Limited | BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE FRACTIONS AND USES THEREOF |
| JP7670481B2 (ja) | 2017-08-04 | 2025-04-30 | バイスクルテクス・リミテッド | Cd137に対して特異的な二環式ペプチドリガンド |
| TWI825046B (zh) | 2017-12-19 | 2023-12-11 | 英商拜西可泰克斯有限公司 | Epha2特用之雙環胜肽配位基 |
| CA3091775A1 (en) | 2018-02-23 | 2019-08-29 | Bicycletx Limited | Multimeric bicyclic peptide ligands |
| GB201810316D0 (en) | 2018-06-22 | 2018-08-08 | Bicyclerd Ltd | Peptide ligands for binding to EphA2 |
| US11180531B2 (en) | 2018-06-22 | 2021-11-23 | Bicycletx Limited | Bicyclic peptide ligands specific for Nectin-4 |
| GB201820325D0 (en) | 2018-12-13 | 2019-01-30 | Bicyclerd Ltd | Bicyclic peptide ligands specific for psma |
| GB201820288D0 (en) | 2018-12-13 | 2019-01-30 | Bicycle Tx Ltd | Bicycle peptide ligaands specific for MT1-MMP |
| GB201820295D0 (en) | 2018-12-13 | 2019-01-30 | Bicyclerd Ltd | Bicyclic peptide ligands specific for MT1-MMP |
| WO2020128527A1 (en) | 2018-12-21 | 2020-06-25 | Bicyclerd Limited | Bicyclic peptide ligands specific for pd-l1 |
| EP3897849A1 (en) | 2018-12-21 | 2021-10-27 | BicycleTx Limited | Bicyclic peptide ligands specific for pd-l1 |
| GB201900529D0 (en) | 2019-01-15 | 2019-03-06 | Bicycletx Ltd | Bicyclic peptide ligands specific for CD38 |
| KR20220007098A (ko) | 2019-05-09 | 2022-01-18 | 바이사이클티엑스 리미티드 | Ox40에 특이적인 이환식 펩티드 리간드 |
| TWI860386B (zh) | 2019-07-30 | 2024-11-01 | 英商拜西可泰克斯有限公司 | 異質雙環肽複合物 |
| SI4464721T1 (sl) * | 2019-10-03 | 2025-08-29 | Bicycletx Limited | Heterotandemski biciklični peptidni kompleksi |
| CN116348476A (zh) | 2020-08-03 | 2023-06-27 | 拜斯科技术开发有限公司 | 基于肽的接头 |
| CA3206529A1 (en) * | 2021-01-08 | 2022-07-14 | Bicycletx Limited | Heterotandem bicyclic peptide complexes |
| JP2024504068A (ja) * | 2021-01-08 | 2024-01-30 | バイスクルテクス・リミテッド | 抗感染性二環式ペプチドリガンド |
| US12539335B2 (en) | 2021-09-29 | 2026-02-03 | Conjustar (Zhuhai) Biologics Co., Ltd. | Tricyclic polypeptide conjugated drug and use thereof |
| CN114933638B (zh) * | 2022-05-12 | 2024-07-26 | 厦门大学 | 特异性靶向cd28的多元环肽配体框架 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6927203B1 (en) | 1999-08-17 | 2005-08-09 | Purdue Research Foundation | Treatment of metastatic disease |
| EP1452868A2 (en) | 2003-02-27 | 2004-09-01 | Pepscan Systems B.V. | Method for selecting a candidate drug compound |
| JP6074574B2 (ja) | 2008-02-05 | 2017-02-08 | バイシクル セラピューティクス リミテッド | 方法及び組成物 |
| GB0913775D0 (en) | 2009-08-06 | 2009-09-16 | Medical Res Council | Multispecific peptides |
| WO2012057624A1 (en) | 2010-10-25 | 2012-05-03 | Pepscan Systems B.V. | Novel bicyclic peptide mimetics |
| US9828432B2 (en) * | 2012-02-06 | 2017-11-28 | Providence Health & Services—Oregon | Cancer treatment and monitoring methods using OX40 agonists |
| ES2705068T3 (es) | 2013-05-23 | 2019-03-21 | Ohio State Innovation Foundation | Síntesis química y cribado de bibliotecas de péptidos bicíclicos |
| PT3149025T (pt) | 2014-05-21 | 2019-08-01 | Entrada Therapeutics Inc | Peptídeos penetrantes de células e métodos de fabrico e utilização dos mesmos |
| NZ731185A (en) | 2014-10-29 | 2024-03-22 | Bicyclerd Ltd | Bicyclic peptide ligands specific for mt1-mmp |
| MX2017016844A (es) * | 2015-07-16 | 2018-08-15 | Biokine Therapeutics Ltd | Composiciones y procedimientos para tratar cancer. |
| KR102775461B1 (ko) | 2016-04-01 | 2025-02-28 | 어비디티 바이오사이언시스 인크. | 핵산-폴리펩타이드 조성물 및 이의 용도 |
| BR112018071612A2 (pt) | 2016-04-22 | 2019-02-19 | Alligator Bioscience Ab | polipeptídeos biespecíficos inovadores contra cd137 |
| GB201607827D0 (en) * | 2016-05-04 | 2016-06-15 | Bicycle Therapeutics Ltd | Bicyclic peptide-toxin conjugates specific for MT1-MMP |
| EP3559018A1 (en) | 2016-12-23 | 2019-10-30 | Bicyclerd Limited | Peptide derivatives having novel linkage structures |
| BR112019017628A2 (pt) | 2017-02-24 | 2020-07-07 | Macrogenics, Inc. | molécula de ligação a cd137 x ta, composições farmacêuticas, uso da molécula de ligação a cd137 x ta, molécula de ligação a cd137, uso da molécula de ligação a cd137, molécula de ligação a her2/neu, uso da molécula de ligação a her2/neu, e uso de uma composição |
| JP7670481B2 (ja) | 2017-08-04 | 2025-04-30 | バイスクルテクス・リミテッド | Cd137に対して特異的な二環式ペプチドリガンド |
| TWI825046B (zh) | 2017-12-19 | 2023-12-11 | 英商拜西可泰克斯有限公司 | Epha2特用之雙環胜肽配位基 |
| GB201721265D0 (en) | 2017-12-19 | 2018-01-31 | Bicyclerd Ltd | Bicyclic peptide ligands specific for EphA2 |
| CA3091775A1 (en) | 2018-02-23 | 2019-08-29 | Bicycletx Limited | Multimeric bicyclic peptide ligands |
| CA3095582A1 (en) | 2018-04-04 | 2019-10-10 | Bicycletx Limited | Heterotandem bicyclic peptide complexes |
| US11180531B2 (en) | 2018-06-22 | 2021-11-23 | Bicycletx Limited | Bicyclic peptide ligands specific for Nectin-4 |
| GB201810316D0 (en) | 2018-06-22 | 2018-08-08 | Bicyclerd Ltd | Peptide ligands for binding to EphA2 |
| WO2020084305A1 (en) | 2018-10-23 | 2020-04-30 | Bicycletx Limited | Bicyclic peptide ligands and uses thereof |
| EP3897849A1 (en) | 2018-12-21 | 2021-10-27 | BicycleTx Limited | Bicyclic peptide ligands specific for pd-l1 |
| US20220184222A1 (en) | 2019-04-02 | 2022-06-16 | Bicycletx Limited | Bicycle toxin conjugates and uses thereof |
| KR20220007098A (ko) | 2019-05-09 | 2022-01-18 | 바이사이클티엑스 리미티드 | Ox40에 특이적인 이환식 펩티드 리간드 |
| TWI860386B (zh) | 2019-07-30 | 2024-11-01 | 英商拜西可泰克斯有限公司 | 異質雙環肽複合物 |
| SI4464721T1 (sl) | 2019-10-03 | 2025-08-29 | Bicycletx Limited | Heterotandemski biciklični peptidni kompleksi |
| CN114760988A (zh) | 2019-11-27 | 2022-07-15 | 拜斯科技术开发有限公司 | 对EphA2具有特异性的双环肽配体和其用途 |
| EP4165414A1 (en) | 2020-06-12 | 2023-04-19 | BicycleTX Limited | Treatment of diseases characterized by overexpression of erythropoietin-producing hepatocellular receptor a2 (epha2) |
-
2020
- 2020-05-11 KR KR1020217039675A patent/KR20220007098A/ko not_active Ceased
- 2020-05-11 CN CN202080033959.9A patent/CN113811541A/zh active Pending
- 2020-05-11 EP EP20728128.8A patent/EP3965827A1/en not_active Withdrawn
- 2020-05-11 MX MX2021013669A patent/MX2021013669A/es unknown
- 2020-05-11 CA CA3137095A patent/CA3137095A1/en active Pending
- 2020-05-11 WO PCT/GB2020/051144 patent/WO2020225577A1/en not_active Ceased
- 2020-05-11 SG SG11202111606TA patent/SG11202111606TA/en unknown
- 2020-05-11 AU AU2020269506A patent/AU2020269506A1/en not_active Abandoned
- 2020-05-11 JP JP2021566259A patent/JP2022532134A/ja active Pending
- 2020-05-11 US US16/872,097 patent/US11613560B2/en active Active
- 2020-05-11 BR BR112021022315A patent/BR112021022315A2/pt not_active IP Right Cessation
-
2021
- 2021-11-07 IL IL287881A patent/IL287881A/en unknown